Fairfield, Bush & Co’s RXO RXO Stock Holding History

Fairfield, Bush & Co’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,020	Closed	-$47K	–	402
2023 Q4	$47K	Buy	+2,020	New	+$40.6K	0.03%	198
2023 Q3	–	Sell	-3,020	Closed	-$68.5K	–	419
2023 Q2	$68.5K	Buy	+3,020	New	+$60.8K	0.02%	202

Other funds holding RXO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fairfield, Bush & Co's RXO Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of RXO (RXO) in Q1 2024, closing a stake of 2,020 shares — an estimated $47K sold.

Fairfield, Bush & Co first reported a position in RXO in Q2 2023 and held it in 2 quarters. The position peaked at $68.5K in Q2 2023. 241 funds tracked by Wall St. Rank hold RXO as of Q1 2024.

Fairfield, Bush & Co reported no remaining RXO position as of Q1 2024 after selling out during the quarter.
Fairfield, Bush & Co sold 2,020 RXO shares in Q1 2024, an estimated $47K.
Fairfield, Bush & Co first reported a position in RXO in Q2 2023 and held it in 2 quarters.
Fairfield, Bush & Co's RXO position peaked at $68.5K in Q2 2023.
241 funds tracked by Wall St. Rank held RXO as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.